← Back to Clinical Trials
Recruiting NCT06420141

NCT06420141 The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06420141
Status Recruiting
Phase
Sponsor Indiana University
Condition Neuropathic Pain
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2024-01-03
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2024-01-03 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This application addresses the Peer Reviewed Medical Research Program Investigator-Initiated Research Award FY21 W81XWH-22-CPMRP-IIRA area of Chronic Pain Management Research Program- The investigators will utilize subjects who have sustained ankle fractures and may develop chronic pain following bone union. No attempt will be made to affect the experimental outcome in the subjects. This study will adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of research.

Eligibility Criteria

Fracture Group: Inclusion Criteria: 1. 18-85 years old 2. an isolated rotational ankle (AO/OTA 44 types A-C) fracture that is treated operatively 3. Abbreviated Injury Scale \< 3 for non-extremity body systems 4. can speak, read, and understand English Exclusion Criteria: 1. treated for a chronic pain condition prior to their qualifying injury 2. on a pain contract 3. pathologic fracture 4. Daily use of gabapentin or opiods prior to enrollment Control Group: Inclusion Criteria: 1. 18-85 years of age 2. can speak, read, and understand English Exclusion Criteria: 1. Chronic pain or an ongoing acute pain condition 2. Currently or have previously sustained a bone fracture 3. Current Pain medication usage 4. Any previous orthopaedic surgical procedures 5. Must have been free of any surgeries for at least 5 years 6. Peripheral neuropathy 7. Individuals having had a major surgery or a major disease or condition, as determined by the PI, such as cardiovascular disease, metabolic disorders, renal disease, neurological disorders, or severe psychiatric conditions.

Contact & Investigator

Central Contact

Fletcher A White, PhD

✉ fawhite@iu.edu

📞 317-274-5264

Principal Investigator

Roman Natoli, MD, PhD

PRINCIPAL INVESTIGATOR

Indiana University

Frequently Asked Questions

Who can join the NCT06420141 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Neuropathic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06420141 currently recruiting?

Yes, NCT06420141 is actively recruiting participants. Contact the research team at fawhite@iu.edu for enrollment information.

Where is the NCT06420141 trial being conducted?

This trial is being conducted at Indianapolis, United States.

Who is sponsoring the NCT06420141 clinical trial?

NCT06420141 is sponsored by Indiana University. The principal investigator is Roman Natoli, MD, PhD at Indiana University. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology